High BCAR1 expression was not correlated with poorer overall survival among breast cancer and lung adenocarcinoma patients with wild-type TP53. This suggests, at least in part, high BCAR1 expression itself is insufficient to drive breast cancer progression without the cooperation of mutant TP53. This evidence concerns the gene TP53 and breast carcinoma.